Combination of irreversible electroporation with sustained release of a synthetic membranolytic polymer for enhanced cancer cell killing
Irreversible electroporation (IRE) is used clinically as a focal therapy to ablate solid tumors. A critical disadvantage of IRE as a monotherapy for cancer is the inability of ablating large tumors, because the electric field strength required is often too high to be safe. Previous reports indicate...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144369/ https://www.ncbi.nlm.nih.gov/pubmed/34031433 http://dx.doi.org/10.1038/s41598-021-89661-y |